Results 211 to 220 of about 16,509 (300)
Recent Advances and Challenges in Ammonia‐Hydrogen Energy Conversion
Advanced Science, EarlyView.This work summarizes the latest progress of various catalytic methods in ammonia‐hydrogen energy conversion. The challenges and outlook of ammonia‐hydrogen energy conversion system are also emphasized. This work expects to build a blueprint of renewable and efficient ammonia‐hydrogen energy conversion systems under mild conditions.
Menghao Lv +6 more
wiley +1 more source
Advanced Science, EarlyView.The integration of ROS‐generating systems with H2S depletion strategies effectively overcomes the limitations imposed by endogenous antioxidant defenses on ROS‐based antimicrobial therapies. In this study, the Cu‐MOF is incorporated into pillararene‐embedded COF, achieving a “three‐in‐one” antimicrobial effect that markedly alleviated periodontal ...
Shuang Liang +9 more
wiley +1 more source
Superlattice Architectures for Advancing Photothermal Catalysis: Mechanisms and Applications
Advanced Science, EarlyView.This paper provides a timely overview of superlattice architectures in photothermal catalysis, with a systematic review on mechanisms at both atomic and macroscopic scales in different processes, challenges, and future opportunities. ABSTRACT Photothermal catalysis has emerged as a powerful strategy to complement photocatalysis by harnessing full ...
Yuzhao Wu +5 more
wiley +1 more source
A P/N type silicon semiconductor loaded with silver nanoparticles used as a SERS substrate to selectively drive the coupling reaction induced by surface plasmons. [PDF]
Nanoscale Adv, 2020 Zhao Y, Zhang Q, Ma L, Song P, Xia L.
europepmc +1 more source
Ciclopirox Olamine Inhibits the NLRP3 Inflammasome to Alleviate Inflammatory Diseases
Advanced Science, EarlyView.There is no drug targeting the NLRP3 inflammasome that has been approved for use in clinical settings. Ciclopirox olamine (CPX), an antifungal agent approved by the US Food and Drug Administration (FDA), is identified as a specific and potent NLRP3 inflammasome inhibitor. CPX targets the NACHT domain of NLRP3 at Y381 to impair NLRP3 oligomerization and
Xinyu Xia +7 more
wiley +1 more source
Geometry‐Controlled Assembly of Self‐Standing Nanorods With Undisturbed Plasmonics
Advanced Science, EarlyView.This study reports a geometry‐driven assembly strategy to vertically align Au@Ag core–shell nanorods on PS beads. This well‐defined architecture enables the preservation of the intrinsic optical response of individual nanorods. Thus, demonstrate a highly reproducible SERS enhancement with exceptional uniformity.
Yoel Negrin‐Montecelo +5 more
wiley +1 more source
High-Performance Transmission of Surface Plasmons in Graphene-Covered Nanowire Pairs with Substrate. [PDF]
Nanomaterials (Basel), 2019 Teng D, Wang K, Huan Q, Zhao Y, Tang Y.
europepmc +1 more source
Advanced Science, EarlyView.Dual targeting of ANGPTL3 and IL‐33/ST2 attenuates diabetic kidney disease by reprogramming lipid–inflammatory crosstalk. This strategy reduces renal lipotoxicity, suppresses inflammatory activation, and limits fibrotic remodeling, thereby preserving kidney structure and function and highlighting a mechanism‐guided therapeutic approach for metabolic ...
Zhuojin Li +8 more
wiley +1 more source
Advanced Science, EarlyView.The aptamer WHY‐3E identifies PrPC as a CRC driver. Stabilized by USP18, endocytosed PrPC forms a LYN/STAT3 complex, upregulating MSN transcription to promote metastasis. Crucially, WHY‐3E sensitively detects PrPC‐positive circulating exosomes, establishing a robust theoretical foundation for non‐invasive clinical diagnostics.
Chunlin Wang +23 more
wiley +1 more source
Phase-controlled propagation of surface plasmons. [PDF]
Light Sci Appl, 2017 Sain B, Kaner R, Prior Y.
europepmc +1 more source